Table 3.
Rank of PIMs prescribing claims by sex.
| Rank* | Total period of research (2015~2021) | |
|---|---|---|
| Male | Female | |
| 1 | Tamsulosin | Eperisone |
| 2 | Eperisone | Cimetidine |
| 3 | Cimetidine | Levosulpiride |
| 4 | Levosulpiride | Alprazolam |
| 5 | Prednisolone | Prednisolone |
| 6 | Alprazolam | Zolpidem |
| 7 | Zolpidem | Gabapentin |
| 8 | Terazosin | Etizolam |
| 9 | Gabapentin | Ferrous sulfate |
| 10 | Alfuzosin | Risedronate |
PIMs = potentially inappropriate medications.
indicates that duplicated cases were removed.